Medicina
Departamento
Hospital de Jerez
Jerez, EspañaPublicacións en colaboración con investigadores/as de Hospital de Jerez (30)
2024
2023
-
Genomics improves risk stratifi cation of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials
Haematologica, Vol. 108, Núm. 4, pp. 969-980
-
Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)
Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031
2022
-
Usefulness of the 5MPB-Toledo model to predict bacteremia in the elderly patient
Infectio, Vol. 26, Núm. 2, pp. 128-136
2021
-
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study
Liver Transplantation, Vol. 27, Núm. 12, pp. 1767-1778
2020
-
Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease
Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024
-
Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience
Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002
2019
-
Association of candidate gene polymorphisms with chronic kidney disease: Results of a case-control analysis in the NEFRONA cohort
Frontiers in Genetics, Vol. 10, Núm. FEB
-
Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group
British Journal of Haematology, Vol. 184, Núm. 5, pp. 797-807
-
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364
-
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation
American Journal of Transplantation, Vol. 19, Núm. 11, pp. 3176-3184
-
Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology
Reumatologia Clinica, Vol. 15, Núm. 5, pp. 252-257
2018
-
Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia
British Journal of Haematology
-
Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy
Leukemia, Vol. 32, Núm. 1, pp. 21-29
2017
-
Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: Results of a randomized, double-blind clinical trial
BMC Psychiatry, Vol. 17, Núm. 1
-
Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study
Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520
-
Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253
2016
-
Urine metabolome profiling of immune-mediated inflammatory diseases
BMC Medicine, Vol. 14, Núm. 1
2015
-
A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk
Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1875-1881
-
Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease
Nephrology Dialysis Transplantation, Vol. 30, Núm. 7, pp. 1176-1185